Based on our results, 4βHWE treatment suppressed the β-catenin/TCF transcriptional activity and the Wnt downstream target gene expression of cyclin D1, c-Myc, and Axin 2 in CRC. Here, AXIN2 is linked to colorectal carcinoma.